NVIV - インビボ・セラピュ―ティクス・ホ―ルディングス (InVivo Therapeutics Holdings Corp.)

NVIVのニュース

   Holding stocks: Evofem Biosciences, Inc. (NASDAQ:EVFM -0.28%), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV 0.01%)  2021/08/30 23:12:14 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Holding stocks: Evofem Biosciences, Inc. (NASDAQ:EVFM -0.28%), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV 0.01%) appeared first on Stocks Equity .
   Volume Buzzers: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Impac Mortgage Holdings, Inc. (AMEX:IMH)  2021/08/25 21:47:25 Stock Equity
InVivo Therapeutics Holdings Corp. (NVIV) with the stream of 4.92% also noticed, India Impac Mortgage Holdings, Inc. (IMH) encountered a rapid change of 1.39% in the last hour of Wednesdays The post Volume Buzzers: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Impac Mortgage Holdings, Inc. (AMEX:IMH) appeared first on Stocks Equity .
   Is It Time to move on for: AeroCentury Corp. (AMEX:ACY), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV)  2021/08/16 00:28:33 Stock Equity
AeroCentury Corp. (ACY) with the stream of 10.42% also noticed, India InVivo Therapeutics Holdings Corp. (NVIV) encountered a rapid change of -1.82% in the last hour of trading session. AeroCentury The post Is It Time to move on for: AeroCentury Corp. (AMEX:ACY), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) appeared first on Stocks Equity .
   Most Prominent Stock: MoSys, Inc. (NASDAQ:MOSY), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV)  2021/08/05 22:05:19 Stock Equity
MoSys, Inc. (MOSY) with the stream of -3.88% also noticed, India InVivo Therapeutics Holdings Corp. (NVIV) encountered a rapid change of -1.35% in the last hour of Thursdays trading session. The post Most Prominent Stock: MoSys, Inc. (NASDAQ:MOSY), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) appeared first on Stocks Equity .
   Bustling Stock: New Oriental Education & Technology Group Inc. (NYSE:EDU), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV)  2021/07/27 22:29:49 Stock Equity
New Oriental Education & Technology Group Inc. (NYSE:EDU) with the stream of 12.89% also noticed, India InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) encountered a rapid change of 0.62% in the last The post Bustling Stock: New Oriental Education & Technology Group Inc. (NYSE:EDU), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) appeared first on Stocks Equity .
   An Eye on Data: The Trade Desk, Inc. (NASDAQ:TTD), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV)  2021/06/24 21:52:22 Stock Equity
The Trade Desk, Inc. (NASDAQ:TTD) with the stream of 15.98% also noticed, India InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) encountered a rapid change of -0.03% in the last hour of Thursdays The post An Eye on Data: The Trade Desk, Inc. (NASDAQ:TTD), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) appeared first on Stocks Equity .
   Is Invivo Therapeutics (NVIV) A Good Stock To Buy Now?  2021/06/14 03:22:40 Insider Monkey
   InVivo Therapeutics Holdings Corp Shares Close the Week 20.4% Lower - Weekly Wrap  2021/04/16 22:30:00 Kwhen Finance
InVivo Therapeutics Holdings Corp shares closed this week 20.4% lower than it did at the end of last week. The stock is currently down 8.7% year-to-date, down 47.5% over the past 12 months, and down 99.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.4%. Trading Activity Shares traded as high as $0.93 and as low as $0.72 this week.Shares closed 7e+1% below its 52-week high and 5e+1% above its 52-week low.Trading volume this week was 17.8% higher than the 10-day average and 13.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 6.3% lower than its 5-day moving average, 22.6% lower than its 20-day moving average, and 29.8% lower than its 90-day moving average. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -361.7% The company's stock price performance over the past 12 months lags the peer average by -2482.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   InVivo Therapeutics Holdings Corporation Shares Close the Day 20.3% Higher - Daily Wrap  2021/03/05 22:30:00 Kwhen Finance
InVivo Therapeutics Holdings Corporation shares closed today 20.3% higher than it did at the end of yesterday. The stock is currently up 34.6% year-to-date, down 77.8% over the past 12 months, and down 99.5% over the past five years. Today, the Dow Jones Industrial Average rose 1.8%, and the S&P 500 rose 1.8%. Trading Activity Shares traded as high as $1.25 and as low as $0.84 this week.Shares closed 6e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 26.7% higher than the 10-day average and 31.7% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1062.6% The company's stock price performance over the past 12 months lags the peer average by -539.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   InVivo Therapeutics Holdings Corporation Shares Close the Week 24.8% Lower - Weekly Wrap  2021/02/26 22:30:00 Kwhen Finance
InVivo Therapeutics Holdings Corporation shares closed this week 24.8% lower than it did at the end of last week. The stock is currently up 42.0% year-to-date, down 80.8% over the past 12 months, and down 99.2% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 2.5%. Trading Activity Shares traded as high as $1.65 and as low as $1.08 this week.Shares closed 8e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 36.4% lower than the 10-day average and 59.4% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 8.9% lower than its 5-day moving average, 19.6% lower than its 20-day moving average, and 26.6% higher than its 90-day moving average. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 431.3% The company's stock price performance over the past 12 months lags the peer average by -347.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   InVivo Therapeutics Announces Presentation at Upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference  2021/03/12 13:00:00 Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, which runs from March 17 – March 19 from 9:00 am – 5:00 pm ET. Dr. Toselli’s presentation will provi
   InVivo Therapeutics Announces Presentation at Upcoming 2021 H.C. Wainwright Global Life Sciences Conference  2021/03/05 13:00:00 Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming 2021 H.C. Wainwright Global Life Sciences Conference. The conference is scheduled to be held March 9-10, 2021 in a virtual format. Dr. Toselli’s presentation will provide an ove
   InVivo Therapeutics Announces Publication in Peer-Reviewed Journal of Neurosurgery: Spine  2021/02/16 13:00:00 Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the recent publication of a peer-reviewed manuscript in the Journal of Neurosurgery: Spine describing the previously presented complete six-month primary endpoint results from the company's single-arm INSPIRE 1.0 study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury), titled “A study of
   InVivo Therapeutics may delivered a positive earnings surprise Stock market Insights & financial analysis  2020/12/31 16:20:00 Stock Market Daily
InVivo Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   InVivo Therapeutics Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2020/12/24 17:10:00 Stock Market Daily
InVivo Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…

calendar